Cliff Asness’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.58B | Sell |
27,357,486
-2,273,619
| -8% | -$131M | 0.55% | 13 |
|
|
2026
Q1 | $1.8B | Buy |
29,631,105
+3,834,200
| +15% | +$224M | 0.82% | 6 |
|
|
2025
Q4 | $1.39B | Buy |
25,796,905
+16,332,924
| +173% | +$786M | 0.73% | 8 |
|
|
2025
Q3 | $426M | Buy |
9,463,981
+3,396,041
| +56% | +$159M | 0.27% | 66 |
|
|
2025
Q2 | $281M | Buy |
6,067,940
+98,910
| +2% | +$4.86M | 0.23% | 92 |
|
|
2025
Q1 | $364M | Buy |
5,969,030
+1,962,233
| +49% | +$114M | 0.38% | 45 |
|
|
2024
Q4 | $227M | Buy |
4,006,797
+106,630
| +3% | +$5.96M | 0.29% | 59 |
|
|
2024
Q3 | $200M | Buy |
3,900,167
+1,223,871
| +46% | +$57.4M | 0.28% | 68 |
|
|
2024
Q2 | $111M | Buy |
2,676,296
+327,824
| +14% | +$14.7M | 0.17% | 149 |
|
|
2024
Q1 | $126M | Buy |
2,348,472
+246,701
| +12% | +$12.6M | 0.22% | 113 |
|
|
2023
Q4 | $108M | Sell |
2,101,771
-153,229
| -7% | -$8.04M | 0.2% | 113 |
|
|
2023
Q3 | $131M | Sell |
2,255,000
-654,731
| -23% | -$40.1M | 0.27% | 77 |
|
|
2023
Q2 | $186M | Buy |
2,909,731
+168,024
| +6% | +$11.3M | 0.4% | 47 |
|
|
2023
Q1 | $189M | Buy |
2,741,707
+511,072
| +23% | +$36M | 0.42% | 43 |
|
|
2022
Q4 | $160M | Buy |
2,230,635
+598,538
| +37% | +$45.1M | 0.36% | 49 |
|
|
2022
Q3 | $116M | Buy |
1,632,097
+66,803
| +4% | +$4.85M | 0.28% | 75 |
|
|
2022
Q2 | $120M | Buy |
1,565,294
+119,402
| +8% | +$9.09M | 0.27% | 75 |
|
|
2022
Q1 | $106M | Sell |
1,445,892
-79,802
| -5% | -$5.36M | 0.2% | 112 |
|
|
2021
Q4 | $95.1M | Sell |
1,525,694
-31,691
| -2% | -$1.86M | 0.17% | 136 |
|
|
2021
Q3 | $92.2M | Sell |
1,557,385
-454,820
| -23% | -$30M | 0.17% | 144 |
|
|
2021
Q2 | $134M | Sell |
2,012,205
-738,957
| -27% | -$48.2M | 0.23% | 102 |
|
|
2021
Q1 | $173M | Sell |
2,751,162
-80,939
| -3% | -$5.04M | 0.28% | 74 |
|
|
2020
Q4 | $173M | Sell |
2,832,101
-391,849
| -12% | -$24.1M | 0.31% | 65 |
|
|
2020
Q3 | $193M | Sell |
3,223,950
-184,333
| -5% | -$11.1M | 0.33% | 60 |
|
|
2020
Q2 | $196M | Sell |
3,408,283
-625,065
| -15% | -$37.4M | 0.32% | 69 |
|
|
2020
Q1 | $223M | Buy |
4,033,348
+363,125
| +10% | +$22.2M | 0.38% | 61 |
|
|
2019
Q4 | $234M | Buy |
3,670,223
+633,429
| +21% | +$36.3M | 0.27% | 100 |
|
|
2019
Q3 | $154M | Sell |
3,036,794
-4,643,327
| -60% | -$218M | 0.18% | 146 |
|
|
2019
Q2 | $347M | Sell |
7,680,121
-820,972
| -10% | -$38.2M | 0.39% | 55 |
|
|
2019
Q1 | $400M | Sell |
8,501,093
-18,893
| -0.2% | -$941K | 0.42% | 49 |
|
|
2018
Q4 | $443M | Buy |
8,519,986
+2,298,527
| +37% | +$123M | 0.51% | 42 |
|
|
2018
Q3 | $386M | Buy |
6,221,459
+1,013,134
| +19% | +$60.1M | 0.37% | 63 |
|
|
2018
Q2 | $288M | Buy |
5,208,325
+1,865,193
| +56% | +$101M | 0.29% | 84 |
|
|
2018
Q1 | $211M | Sell |
3,343,132
-729,867
| -18% | -$47M | 0.23% | 106 |
|
|
2017
Q4 | $250M | Buy |
4,072,999
+988,731
| +32% | +$61.8M | 0.26% | 101 |
|
|
2017
Q3 | $197M | Buy |
3,084,268
+832,608
| +37% | +$48.6M | 0.23% | 107 |
|
|
2017
Q2 | $125M | Buy |
2,251,660
+1,772,855
| +370% | +$96.5M | 0.17% | 166 |
|
|
2017
Q1 | $26M | Buy |
478,805
+69,477
| +17% | +$3.81M | 0.03% | 535 |
|
|
2016
Q4 | $23.9M | Sell |
409,328
-405,756
| -50% | -$22.2M | 0.03% | 558 |
|
|
2016
Q3 | $43.9M | Buy |
815,084
+201,613
| +33% | +$13M | 0.07% | 392 |
|
|
2016
Q2 | $45.1M | Sell |
613,471
-204,936
| -25% | -$14.5M | 0.08% | 344 |
|
|
2016
Q1 | $52.3M | Sell |
818,407
-376,506
| -32% | -$23.7M | 0.09% | 295 |
|
|
2015
Q4 | $82.2M | Sell |
1,194,913
-761,854
| -39% | -$50.3M | 0.14% | 193 |
|
|
2015
Q3 | $116M | Buy |
1,956,767
+593,640
| +44% | +$37.7M | 0.23% | 114 |
|
|
2015
Q2 | $90.7M | Buy |
1,363,127
+888,048
| +187% | +$58.5M | 0.18% | 159 |
|
|
2015
Q1 | $30.6M | Buy |
475,079
+53,300
| +13% | +$3.34M | 0.07% | 310 |
|
|
2014
Q4 | $24.9M | Sell |
421,779
-713,475
| -63% | -$40.2M | 0.05% | 421 |
|
|
2014
Q3 | $58.1M | Buy |
1,135,254
+137,868
| +14% | +$6.89M | 0.16% | 167 |
|
|
2014
Q2 | $48.4M | Buy |
997,386
+422,926
| +74% | +$20.8M | 0.13% | 211 |
|
|
2014
Q1 | $29.8M | Buy |
574,460
+90,445
| +19% | +$4.81M | 0.09% | 269 |
|
|
2013
Q4 | $25.7M | Buy |
484,015
+152,821
| +46% | +$7.78M | 0.08% | 314 |
|
|
2013
Q3 | $15.3M | Buy |
331,194
+1,793
| +0.5% | +$78.7K | 0.05% | 419 |
|
|
2013
Q2 | $14.7M | Buy |
+329,401
| New | +$14.3M | 0.05% | 436 |
|
Other funds holding BMY
Cliff Asness's BMY Position: Q2 2026 in Review
Cliff Asness reduced its Bristol-Myers Squibb (BMY) stake by 7.7% in Q2 2026, selling an estimated $131M and leaving 27,357,486 shares worth $1.58B. The position accounts for 0.55% of the portfolio, ranked #13.
Cliff Asness first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.8B in Q1 2026. 2,506 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Cliff Asness held 27,357,486 shares of Bristol-Myers Squibb worth $1.58B as of Q2 2026.
- Cliff Asness sold 2,273,619 Bristol-Myers Squibb shares in Q2 2026, an estimated $131M.
- Bristol-Myers Squibb made up 0.55% of Cliff Asness's portfolio in Q2 2026, its #13 holding.
- Cliff Asness first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
- Cliff Asness's Bristol-Myers Squibb position peaked at $1.8B in Q1 2026.
- 2,506 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.